Lunasin and Its Epigenetic Impact in Cancer Chemoprevention

Int J Mol Sci. 2023 May 24;24(11):9187. doi: 10.3390/ijms24119187.

Abstract

Cancer diseases are a leading cause of death worldwide. Therefore, it is pivotal to search for bioactive dietary compounds that can avert tumor development. A diet rich in vegetables, including legumes, provides chemopreventive substances, which have the potential to prevent many diseases, including cancer. Lunasin is a soy-derived peptide whose anti-cancer activity has been studied for over 20 years. The results of the previous research have shown that lunasin inhibits histone acetylation, regulates the cell cycle, suppresses proliferation and induces apoptosis of cancer cells. Thus, lunasin seems to be a promising bioactive anti-cancer agent and a potent epigenetic modulator. The present review discusses studies of the underlying molecular mechanisms and new perspectives on lunasin application in epigenetic prevention and anti-cancer therapy.

Keywords: DNA methylation; chemoprevention; epigenetic anti-cancer therapy; epinutrient; histone acetylation; lunasin.

Publication types

  • Review

MeSH terms

  • Chemoprevention
  • Epigenesis, Genetic
  • Histones* / metabolism
  • Humans
  • Neoplasms* / drug therapy
  • Neoplasms* / genetics
  • Neoplasms* / prevention & control
  • Soybean Proteins / metabolism

Substances

  • Histones
  • Soybean Proteins